Latest Blog Posts Tagged "CVT-301"
February 09, 2017
Pharmaceutical company Acorda reported positive results from a Phase III trial of an inhaled form of levodopa to treat "off" periods in Parkinson's.
June 26, 2015
MJFF staff share news from the 19th International Congress of Parkinson's Disease and Movement Disorders last week in San Diego.
June 16, 2014
CEO Todd Sherer, PhD, talks to Dave Iverson about why levodopa loses efficacy over time and new therapies in development to even out on/off cycles.